These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Breastmilk feeding for mothers and infants with opioid exposure: What is best? Bogen DL; Whalen BL Semin Fetal Neonatal Med; 2019 Apr; 24(2):95-104. PubMed ID: 30922811 [TBL] [Abstract][Full Text] [Related]
49. Autonomous Care Pathway to Patient Opioid Abstinence: Should All Programs Offer this Approach? Patel A; Dietz P; Casto A; DePond J; Taylor L; Seybold D; Blake A; Calhoun B Issues Law Med; 2021; 36(2):193-210. PubMed ID: 36629776 [TBL] [Abstract][Full Text] [Related]
50. Could prenatal food insecurity influence neonatal abstinence syndrome severity? Rose-Jacobs R; Trevino-Talbot M; Lloyd-Travaglini C; Cabral HJ; Vibbert M; Saia K; Wachman EM Addiction; 2019 Feb; 114(2):337-343. PubMed ID: 30422365 [TBL] [Abstract][Full Text] [Related]
51. Hospital Readmissions Among Infants With Neonatal Opioid Withdrawal Syndrome. Gaither JR; Drago MJ; Grossman MR; Li Y; Shabanova V; Xu X; Leventhal JM JAMA Netw Open; 2024 Sep; 7(9):e2435074. PubMed ID: 39316398 [TBL] [Abstract][Full Text] [Related]
52. A review of the literature: How does prenatal opioid exposure impact placental health and fetal brain development? Humphries A; Simcox K; Howell B Dev Psychobiol; 2023 Apr; 65(3):e22378. PubMed ID: 36946682 [TBL] [Abstract][Full Text] [Related]
53. Prenatal opioid-exposed infant extracellular miRNA signature obtained at birth predicts severity of neonatal opioid withdrawal syndrome. Mahnke AH; Roberts MH; Leeman L; Ma X; Bakhireva LN; Miranda RC Sci Rep; 2022 Apr; 12(1):5941. PubMed ID: 35396369 [TBL] [Abstract][Full Text] [Related]
55. Characterization of neonatal opioid withdrawal syndrome in Arizona from 2010-2017. Eaves ER; Barber J; Whealy R; Clancey SA; Wright R; Cocking JH; Spadafino J; Hepp CM PLoS One; 2021; 16(6):e0248476. PubMed ID: 34081702 [TBL] [Abstract][Full Text] [Related]
56. Factors Associated With the Need for Pharmacological Management of Neonatal Opioid Withdrawal Syndrome. Scott LF; Guilfoy V; Duwve JM; Rawl SM Adv Neonatal Care; 2020 Oct; 20(5):364-373. PubMed ID: 32868586 [TBL] [Abstract][Full Text] [Related]
57. The Time is NOW: Filling the Gaps in Treatment of Opioid-Exposed Infants: A Prospective, Pragmatic, Randomized Control Drug Trial. Czynski AJ; Laptook AR R I Med J (2013); 2021 Apr; 104(3):17-21. PubMed ID: 33789403 [TBL] [Abstract][Full Text] [Related]
58. Maternal Opioid Use Disorder and the Risk of Postneonatal Infant Mortality. Grossarth S; Osmundson SS; Wiese AD; Phillips SE; Pham A; Leech AA; Patrick SW; Spieker AJ; Grijalva CG; Adgent MA JAMA Pediatr; 2023 Jul; 177(7):675-683. PubMed ID: 37155175 [TBL] [Abstract][Full Text] [Related]
59. Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome. Chavan NR; Ashford KB; Wiggins AT; Lofwall MR; Critchfield AS AJP Rep; 2017 Oct; 7(4):e215-e222. PubMed ID: 29226017 [No Abstract] [Full Text] [Related]
60. A protocol for enhancing the diagnostic accuracy and predictive validity of neonatal opioid withdrawal syndrome: The utility of non-invasive clinical markers. Maylott SE; Lester BM; Brown L; Castano AJ; Dansereau L; Crowell SE; Deboeck P; Salisbury A; Conradt E PLoS One; 2024; 19(9):e0306176. PubMed ID: 39255286 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]